Impact of Carbon Ion Radiotherapy on Inoperable Bone Sarcoma
暂无分享,去创建一个
T. Nakano | T. Ohno | M. Okamoto | T. Kaminuma | Kenichi Saito | T. Yanagawa | H. Chikuda | H. Kiyohara | K. Shibuya | Shintaro Shiba | Shohei Okazaki | Isaku Kohama
[1] H. Yoshikawa,et al. Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma. , 2020, Cancer.
[2] K. Shirabe,et al. Sacral and Rectal Necrosis after Carbon Ion Radiotherapy Reconstructed with Transpelvic Rectus Abdominis Flap , 2020, Plastic and reconstructive surgery. Global open.
[3] R. Sasaki,et al. Space-making particle therapy for sarcomas derived from the abdominopelvic region. , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] K. Shirabe,et al. A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study , 2019, Radiation oncology.
[5] M. Neel,et al. Curative‐intent radiotherapy for pediatric osteosarcoma: The St. Jude experience , 2019, Pediatric blood & cancer.
[6] K. Shirabe,et al. Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801) , 2019, Front. Oncol..
[7] T. Yamashita,et al. First-In-Human Phase 1 Study of a Nonwoven Fabric Bioabsorbable Spacer for Particle Therapy: Space-Making Particle Therapy (SMPT) , 2019, Advances in radiation oncology.
[8] K. Shirabe,et al. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] K. Murata,et al. Phase I Study of Carbon Ion Radiotherapy and Image-Guided Brachytherapy for Locally Advanced Cervical Cancer , 2018, Cancers.
[10] Wei Guo,et al. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma? , 2018, Clinical orthopaedics and related research.
[11] N. Araki,et al. Carbon ion radiotherapy for inoperable pediatric osteosarcoma , 2018, Oncotarget.
[12] T. Nakano,et al. Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001) , 2018, Cancer medicine.
[13] Y. Yamada,et al. Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum: A Systematic Review , 2016, Spine.
[14] N. Araki,et al. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases. , 2016, International journal of radiation oncology, biology, physics.
[15] R. Grimer,et al. Osteosarcoma of the pelvis. , 2016, The bone & joint journal.
[16] T. Shirai,et al. Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan , 2015, Physics in medicine and biology.
[17] B. Yeap,et al. Long‐term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas , 2014, Journal of surgical oncology.
[18] H. Honda,et al. Impact of carbon ion radiotherapy for primary spinal sarcoma , 2013, Cancer.
[19] Francesca Albertini,et al. Spot-scanning-based proton therapy for extracranial chordoma. , 2011, International journal of radiation oncology, biology, physics.
[20] A. Niemierko,et al. Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma , 2011, Cancer.
[21] R. Okayasu,et al. Effects of carbon ion beam on putative colon cancer stem cells and its comparison with X-rays. , 2011, Cancer research.
[22] D. Jeon,et al. MFH of Bone and Osteosarcoma Show Similar Survival and Chemosensitivity , 2011, Clinical orthopaedics and related research.
[23] L. Koniaris,et al. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. , 2009, The Journal of bone and joint surgery. American volume.
[24] B. Green,et al. Oncologic and functional outcome following sacrectomy for sacral chordoma. , 2006, The Journal of bone and joint surgery. American volume.
[25] Yoshiyuki Suzuki,et al. Carbon Beam Therapy Overcomes the Radiation Resistance of Uterine Cervical Cancer Originating from Hypoxia , 2006, Clinical Cancer Research.
[26] F. Sim,et al. Operative management of sacral chordoma. , 2005, The Journal of bone and joint surgery. American volume.
[27] Seiichi Matsumoto,et al. The Concept of Curative Margin in Surgery for Bone and Soft Tissue Sarcoma , 2004, Clinical orthopaedics and related research.
[28] Toshifumi Ozaki,et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Susumu Kandatsu,et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] S Minohara,et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. , 1999, International journal of radiation oncology, biology, physics.
[31] D H Leung,et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] R. Imai,et al. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. , 2011, International journal of radiation oncology, biology, physics.
[33] Y. Ku,et al. Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit , 2010, Journal of surgical oncology.
[34] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.